This has included FDA-approved drugs like ergotamine for migraine headaches, pergolide for Parkinson’s disease, and cabergoline for hyperprolactinemia due to off-target 5-HT2B agonist activity [97]. The gene discussed is HTR2B; the disease is hyperprolactinemia.